1 year return (CAGR)
-
Hemab Therapeutics Holdings, Inc. Common Stock Exchange (NASDAQ, USD)
COAG
36.73
-1.52 (-3.97%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
1.72B
Price/Sales
-
Ent value
1.49B
Price/Book
3.78
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 38.38 |
| Daily high | 38.98 |
| Daily low | 34.99 |
| Daily Volume | 417K |
| All-time high | 54.94 |
| 1y analyst estimate | 61.20 |
| Beta | - |
| EPS (TTM) | -2.06 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| COAG | S&P500 | |
| Current price drop from All-time high | -33.15% | -1.29% |
| Highest price drop | -33.15% | -56.47% |
| Date of highest drop | 23 Sep 2026 | 9 Mar 2009 |
| Avg drop from high | -14.23% | -10.68% |
| Avg time to new high | 6 days | 12 days |
| Max time to new high | 39 days | 1805 days |
News
